NKTX NASDAQ
Nkarta, Inc.
1W: -2.3%
1M: -36.3%
3M: -20.2%
YTD: -15.4%
1Y: -15.0%
3Y: +4.3%
5Y: -93.8%
$1.70
-0.13 (-7.10%)
Pre-Market: $1.72 (+0.02, +0.88%)
Weekly Expected Move ±6.1%
$2
$2
$2
$2
$2
Credit Risk of going bust: higher than 83% of companies Debt: 37.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the second-riskiest tenth, about 1 in 87 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.12 (down 93%), Nkarta, Inc. would be worth roughly what it owes.
Total debt $73.5M against a stock market value of $121.8M.
Distance to default 2.35 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $36.8M (short-term plus half of long-term), stock volatility 73.0%; Altman Z'' -3.16. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.12 (down 93%), Nkarta, Inc. would be worth roughly what it owes.
Total debt $73.5M against a stock market value of $121.8M.
Distance to default 2.35 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $36.8M (short-term plus half of long-term), stock volatility 73.0%; Altman Z'' -3.16. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2021-05-06
Earliest Filing
2021-10-22
Latest Filing
partner: 4
Counterparties (Filed by NKTX)
4 relationshipsCompanies named in NKTX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| HCP Life Science REIT Inc. | HCP | partner | Landlord in a lease amendment for additional office and laboratory space. | 2021-10-22 | View |
| CBRE Inc. | CBRE | partner | Real estate broker involved in the negotiation of the lease amendment. | 2021-10-22 | View |
| HCP BTC, LLC | — | partner | Entered into a triple net lease agreement with Nkarta, Inc. for an office building in South San Francisco. | 2021-07-14 | View |
| CRISPR Therapeutics AG | CRSP | partner | Strategic partner for co-developing and co-commercializing gene-edited cell therapies and licensing gene-editing technol | 2021-05-06 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-10 | Earnings Release; Exhibits | View | |
| 2026-06-11 | Shareholder Vote; Exhibits | View | |
| 2026-05-12 | Earnings Release; Exhibits | View | |
| 2026-03-26 | Other Events; Exhibits | View | |
| 2026-03-25 | Earnings Release; Exhibits | View | |
| 2025-11-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-06 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-26 | Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities; De | View | |
| 2024-11-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-08-16 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-08-13 | Entry into Material Definitive Agreement | Agreement | View |
| 2024-07-16 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2024-06-27 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2024-06-13 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2024-05-09 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-03-28 | Other Events; Financial Statements and Exhibits | View | |
| 2024-03-25 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2024-03-21 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR